JP2013528622A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013528622A5 JP2013528622A5 JP2013513360A JP2013513360A JP2013528622A5 JP 2013528622 A5 JP2013528622 A5 JP 2013528622A5 JP 2013513360 A JP2013513360 A JP 2013513360A JP 2013513360 A JP2013513360 A JP 2013513360A JP 2013528622 A5 JP2013528622 A5 JP 2013528622A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- cadherin
- optionally
- composition according
- der
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35150510P | 2010-06-04 | 2010-06-04 | |
| US61/351,505 | 2010-06-04 | ||
| PCT/US2011/039002 WO2011153397A2 (en) | 2010-06-04 | 2011-06-03 | Treatment of inflammatory disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013528622A JP2013528622A (ja) | 2013-07-11 |
| JP2013528622A5 true JP2013528622A5 (https=) | 2014-07-24 |
Family
ID=45067307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013513360A Pending JP2013528622A (ja) | 2010-06-04 | 2011-06-03 | 炎症性障害の処置 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20130209476A1 (https=) |
| EP (1) | EP2575883B1 (https=) |
| JP (1) | JP2013528622A (https=) |
| AU (1) | AU2011261323A1 (https=) |
| CA (1) | CA2805270C (https=) |
| IL (1) | IL223385B (https=) |
| WO (1) | WO2011153397A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130068691A1 (en) * | 2011-08-05 | 2013-03-21 | Henry John Smith | Targeted apheresis for the treatment of rheumatoid arthritis and immune disorders |
| WO2016100301A1 (en) * | 2014-12-15 | 2016-06-23 | The Brigham And Women's Hospital, Inc. | Use of cadherin-11 antagonists to treat obesity-associated conditions and other metabolic disorders |
| US20200181649A1 (en) * | 2016-07-14 | 2020-06-11 | University Of Delaware | Hybrid formulation of responsive polymeric nanocarriers for therapeutic and diagnostic delivery |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5610281A (en) | 1994-05-03 | 1997-03-11 | Brigham & Women's Hospital, Inc. | Antibodies for modulating heterotypic E-cadherin interactions with human T lymphocytes |
| US7481999B2 (en) * | 1998-05-05 | 2009-01-27 | Adherex Technologies, Inc. | Compounds and methods for modulating OB-cadherin-mediated function |
| US6787136B1 (en) * | 1999-09-03 | 2004-09-07 | The Brigham And Women's Hospital, Inc. | Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| CN101613406A (zh) * | 2002-06-06 | 2009-12-30 | 肿瘤疗法科学股份有限公司 | 与人结肠癌相关的基因和多肽 |
| CN101318019B (zh) * | 2003-04-23 | 2012-08-29 | 梅达雷克斯公司 | 含1型干扰素拮抗剂的组合物及其在制备治疗炎症性肠病的药物中的用途 |
| WO2005007175A2 (en) * | 2003-06-09 | 2005-01-27 | The Brigham And Women's Hospital, Inc. | Cadherin directed molecular and cellular localization |
| MY162179A (en) * | 2004-04-01 | 2017-05-31 | Elan Pharm Inc | Steroid sparing agents and methods of using same |
| AU2008251877A1 (en) * | 2007-05-08 | 2008-11-20 | Picobella Llc | Methods for diagnosing and treating prostate and lung cancer |
| US20100322926A1 (en) * | 2008-02-11 | 2010-12-23 | Novartis Ag | Methods of using cadherin 11 (cdh11) antagonists |
| EP3372591B1 (en) * | 2009-02-09 | 2021-05-26 | Georgetown University | Cadherin-11 inhibitors and methods of use thereof |
| KR20130107203A (ko) * | 2010-05-04 | 2013-10-01 | 더 브리검 앤드 우먼즈 하스피털, 인크. | 섬유증의 검출 및 치료 |
| US8877188B2 (en) * | 2010-05-04 | 2014-11-04 | The Brigham And Women's Hospital, Inc. | Detection and treatment of non-dermal fibrosis |
-
2011
- 2011-06-03 US US13/702,018 patent/US20130209476A1/en not_active Abandoned
- 2011-06-03 WO PCT/US2011/039002 patent/WO2011153397A2/en not_active Ceased
- 2011-06-03 JP JP2013513360A patent/JP2013528622A/ja active Pending
- 2011-06-03 AU AU2011261323A patent/AU2011261323A1/en not_active Abandoned
- 2011-06-03 EP EP11790443.3A patent/EP2575883B1/en active Active
- 2011-06-03 CA CA2805270A patent/CA2805270C/en active Active
-
2012
- 2012-12-02 IL IL223385A patent/IL223385B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Qu et al. | Stimulation of sigma‐1 receptor protects against cardiac fibrosis by alleviating IRE1 pathway and autophagy impairment | |
| van Koppen et al. | Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease | |
| Matsumoto et al. | CD44 expression in astrocytes and microglia is associated with ALS progression in a mouse model | |
| Yang et al. | Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats | |
| JP2014526441A5 (https=) | ||
| JP2016517888A5 (https=) | ||
| Momcilović et al. | CXCL12 in control of neuroinflammation | |
| US20230129866A1 (en) | Methods of treating respiratory disease with deupirfenidone | |
| WO2021183774A1 (en) | Treating acute respiratory distress | |
| JP2013528622A5 (https=) | ||
| Su et al. | Silencing of RSPO1 mitigates obesity-related renal fibrosis in mice by deactivating Wnt/β-catenin pathway | |
| Ai et al. | Paeonol ameliorates diabetic nephropathy by promoting TFEB-mediated lysosome biogenesis and lipophagy | |
| Garcia-Dorado et al. | Primary results of the PROMISE trial: myocardial protection with intracoronary adenosine given before reperfusion in patients with STEMI | |
| Govaert et al. | Poor functional recovery after transplantation of diabetic bone marrow stem cells in ischemic myocardium | |
| van Echteld et al. | A view on imaging in drug research and development for respiratory diseases | |
| Wesseling et al. | Mildly increased renin expression in the absence of kidney injury in the murine transverse aortic constriction model | |
| CN106714842A (zh) | 包含双重PI3K δ‑γ激酶抑制剂和皮质类固醇的治疗方法及组合物 | |
| Sababathy et al. | A ‘One Stone, Two Birds’ Approach with Mesenchymal Stem Cells for Acute Respiratory Distress Syndrome and Type Ii Diabetes Mellitus | |
| JP2018500882A5 (https=) | ||
| CN104644620B (zh) | 化合物xl‑001在制备治疗慢性肾脏病的药物中的用途 | |
| JP2014079188A (ja) | 無菌性慢性前立腺炎非ヒトモデル動物、頻尿非ヒトモデル動物およびこれらを用いた被験物質の評価方法 | |
| Church et al. | The artificial placenta rescues premature lambs from Ventilatory failure | |
| Suda et al. | Spherical sulfated cellulose adsorbs high-mobility-group box chromosomal protein 1 in vitro and in vivo | |
| Lieberman et al. | Preliminary Findings from the Phase 2 EPPIK Study of Sparsentan in Pediatric Patients with Selected Proteinuric Glomerular Diseases: SA-OR84 | |
| Cuijpers | A novel paradigm for heart failure with preserved ejection fraction: Working towards understanding the pathology of HFpEF |